Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Receivables - Other (2013 - 2026)

Acadia Pharmaceuticals (ACAD) posted Receivables - Other of $15.7 million for Q2 2026, up 20.36% on a QoQ basis from $13.0 million in Q1 2026, and up 28.79% year-over-year from $12.2 million in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) Receivables - Other (2013 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported Receivables - Other for 14 years, with the latest figure at $15.7 million in Q2 2026.

  • On a quarterly basis, Receivables - Other rose 28.79% year-over-year to $15.7 million in Q2 2026; TTM through Jun 2026 was $15.7 million, a 28.79% increase from a year earlier, with the FY2025 full-year figure at $26.8 million, up 349.53% from the prior year.
  • Receivables - Other was $15.7 million for Q2 2026 at Acadia Pharmaceuticals, up from $13.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $26.8 million in Q4 2025, with the low at $403000.0 in Q3 2022.
  • Average Receivables - Other over 5 years is $8.0 million, with a median of $5.7 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Receivables - Other sank 58.54% in 2022, then soared 602.54% in 2024.
  • Over 5 years, Receivables - Other stood at $885000.0 in 2022, then soared by 361.36% to $4.1 million in 2023, then soared by 45.87% to $6.0 million in 2024, then surged by 349.53% to $26.8 million in 2025, then sank by 41.41% to $15.7 million in 2026.
  • The last three Receivables - Other figures came in at $15.7 million (Q2 2026), $13.0 million (Q1 2026), and $26.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.69 Mn
Mar 31, 2026 13.03 Mn
Dec 31, 2025 26.77 Mn
Sep 30, 2025 23.59 Mn
Jun 30, 2025 12.18 Mn
Mar 31, 2025 7.97 Mn
Dec 31, 2024 5.96 Mn
Sep 30, 2024 12.15 Mn
Jun 30, 2024 6.70 Mn
Mar 31, 2024 5.38 Mn
Dec 31, 2023 4.08 Mn
Sep 30, 2023 1.73 Mn
Jun 30, 2023 2.30 Mn
Mar 31, 2023 4.34 Mn
Dec 31, 2022 885,000.00
Sep 30, 2022 403,000.00
Jun 30, 2022 936,000.00
Mar 31, 2022 769,000.00
Dec 31, 2021 978,000.00
Sep 30, 2021 972,000.00
API Access

Acadia Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ACAD&period=max&api_key=YOUR_API_KEY